This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: National Research Council of Canada. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Scott Houliston: Innovator in Polypeptide Research
Introduction
Scott Houliston is a notable inventor based in Ottawa, Canada, recognized for his contributions to the field of polypeptide research. With a total of three patents to his name, he has made significant advancements in the understanding and application of specific polypeptides.
Latest Patents
One of his latest patents involves the SOAT polypeptide reaction mixture. This invention relates to sialate-O-acetyltransferase (SOAT) polypeptides, nucleic acids that encode these polypeptides, and methods for utilizing them. Another significant patent focuses on α-1,4-galactosyltransferase (CgtD) polypeptides, which includes a polypeptide from strain LIO87 that has been isolated and characterized. This patent describes a method for producing a galactosylated saccharide by contacting an acceptor saccharide containing a terminal galactose with a donor substrate comprising a galactose moiety and one of the CgtD polypeptides.
Career Highlights
Scott Houliston is affiliated with the National Research Council of Canada, where he continues to engage in innovative research. His work has contributed to the advancement of biochemistry and molecular biology, particularly in the area of glycosylation processes.
Collaborations
Throughout his career, Scott has collaborated with esteemed colleagues such as Michel Gilbert and Warren W Wakarchuk, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Scott Houliston stands out as a prominent inventor in the realm of polypeptide research, with a focus on innovative applications that have the potential to influence various scientific fields. His contributions continue to shape the landscape of biochemistry and molecular biology.